ImmunoCellular Therapeutics Ltd. (IMUC) Gained 9.3% or 0.02 To Price $0.24 On Monday


ImmunoCellular Therapeutics Ltd. (IMUC) gained 9.3% or 0.02 to $0.24. It is about 171231 shares traded, which is 95.22% compare to the average total volume 179819. The market cap of IMUC is $9.85 million. The year to date change is -28.05%. The 52 week price range is from $0.17 to $0.55. Price of IMUC have changed -1.60% during last week. It have changed -12.96% over last month, -23.21% over last 3 months, -12.17% over last 6 months and -36.43% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for IMUC is 0.24. The 200-day Moving Averages for IMUC is 0.27. It is 12.50% above current price. The 52-week High is 0.55. It is 129.17% from the current price. The 52-week Low is 0.17. It is -29.17% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of IMUC is 12.36 on 2018-07-31. Short % to float is 5.82%. There are some statistics of IMUC. It is has market cap $9.85 million. The share outstanding is 41.93 million. The average volume is 179819. The percent of top 15 Institution holding is 5.30%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of IMUC is -3687.49%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of IMUC is -209.11%.


Tags:

Share this post